Custom Search

Famciclovir News

US federal appeals court temporarily stops Teva from selling its generic version of the Novartis medicine Famvir

US Court of Appeals for the Federal Circuit issues order prohibiting Teva from selling its generic version

Bell’s palsy usually a mild condition

Although it sounds exotic, Bell’s palsy isn’t all that rare, occurring in 1 of every 4,000 adults per year. Although sounds very serious, it’s usually a mild condition. Caused by the inflammation of the facial, or seventh,...

TAP Enters Into Co-Promotion Agreement for Famvir(R)

Co-Promotion of Genital Herpes Drug Expands Company's Product Offerings, Leverages Vast Experience in Women's Health

USFDA Approved sNDA for Novartis Pharma Corp.’s Antiviral Agent Famvir®

Novartis Pharmaceuticals Corporation's sNDA for Famvir® (famciclovir) tablets has been approved by the USFDA as a single-day treatment for immunocompetent patients with recurrent genital herpes (RGH).

Novartis gets FDA OK for new Famvir indications

The FDA has approved prescription Novartis' Famvir tablets as a single-day treatment for immunocompetent patients with recurrent genital herpes, based on a supplemental new drug application.

Displaying results 1 to 5 out of 11

1

2

3

Next >

Use of this site is subject to the following terms of use